News & Updates

Quantitative sensory testing reliable for pain threshold, tolerance assessment

02 Mar 2022

Quantitative sensory testing (QST) yields reliable measures of pain threshold and tolerance, reveals a new study. However, measurements for sensitivity to changes in temperature are less reliable and may be affected by time and other contextual factors.

Quantitative sensory testing reliable for pain threshold, tolerance assessment

02 Mar 2022

Mucolytics, ICS/LABA combinations cut stroke risk among COPD patients with allied conditions

02 Mar 2022

Patients with chronic obstructive pulmonary disease (COPD) and allied conditions are at heightened risk of stroke, but treatment with mucolytic agents and the combination of inhaled corticosteroids (ICS) plus long-acting β2-agonists (LABA) may protect against the risk, as shown in a study.

Mucolytics, ICS/LABA combinations cut stroke risk among COPD patients with allied conditions

02 Mar 2022

Genes related to general cognition exert no influence on age-related cognitive decline

27 Feb 2022

Common genetic variants associated with general cognition contribute to better verbal memory and semantic fluency in adults, according to a study. However, they appear to have a null effect on age-related cognitive decline.

Genes related to general cognition exert no influence on age-related cognitive decline

27 Feb 2022

Maternal stroke tied to high morbidity, mortality

25 Feb 2022 by

Women who experienced a stroke during pregnancy had higher rates of morbidity and mortality compared with those without stroke, according to a study presented at ISC 2022.

Maternal stroke tied to high morbidity, mortality

25 Feb 2022

DOACs as effective as warfarin for CVT with lower bleeding risk

24 Feb 2022 by

The risk of recurrent venous thrombosis in patients with cerebral venous thrombosis (CVT) was comparable between those who received warfarin or direct oral anticoagulants (DOACs), according to results of the ACTION-CVT* study presented at ISC 2022.

DOACs as effective as warfarin for CVT with lower bleeding risk

24 Feb 2022

Tenecteplase still feasible up to 24 hours after a stroke

24 Feb 2022 by

Intravenous thrombolysis with tenecteplase up to 24 hours after a stroke appears to re-establish blood flow in patients with large-vessel acute ischaemic stroke selected with advanced imaging, the phase IIa CHABLIS-T study has shown.

Tenecteplase still feasible up to 24 hours after a stroke

24 Feb 2022

High BP in young adulthood tied to brain changes in midlife

22 Feb 2022 by

Having high blood pressure (BP) during age 20-40 years appears to be associated with brain changes in midlife which may increase the risk of cognitive decline in later life, according to data from the Coronary Artery Risk Development in Young Adults (CARDIA) study presented at ISC 2022.

High BP in young adulthood tied to brain changes in midlife

22 Feb 2022

Stroke risk elevated first 3 days post–COVID-19 diagnosis

18 Feb 2022 by

Older patients with COVID-19 may have an increased risk of being hospitalized for acute ischaemic stroke (AIS), particularly in the first 3 days following their COVID-19 diagnosis, according to a study presented at ISC 2022.

Stroke risk elevated first 3 days post–COVID-19 diagnosis

18 Feb 2022

Heart attack tied to decline in cognitive function later in life

18 Feb 2022 by

Myocardial infarction (MI) was associated with a rapid decline in cognitive function, such as global cognition, executive function, and memory, years after the event, according to a study presented at ISC 2022.

Heart attack tied to decline in cognitive function later in life

18 Feb 2022

Intra-arterial tPA boosts benefit of stroke thrombectomy

17 Feb 2022 by

Adjunct thrombolysis with intra-arterial alteplase (tPA) following a successful thrombectomy in patients with acute ischaemic stroke due to large vessel occlusion (LVO) significantly improves neurologic outcomes at 90 days, according to the CHOICE* study presented at ISC 2022.

Intra-arterial tPA boosts benefit of stroke thrombectomy

17 Feb 2022

News & Updates

Filter by Specialty:

Specialty:

Quantitative sensory testing reliable for pain threshold, tolerance assessment

Quantitative sensory testing reliable for pain threshold, tolerance assessment

Mucolytics, ICS/LABA combinations cut stroke risk among COPD patients with allied conditions

Mucolytics, ICS/LABA combinations cut stroke risk among COPD patients with allied conditions

Genes related to general cognition exert no influence on age-related cognitive decline

Genes related to general cognition exert no influence on age-related cognitive decline

Maternal stroke tied to high morbidity, mortality

Maternal stroke tied to high morbidity, mortality

DOACs as effective as warfarin for CVT with lower bleeding risk

DOACs as effective as warfarin for CVT with lower bleeding risk

Tenecteplase still feasible up to 24 hours after a stroke

Tenecteplase still feasible up to 24 hours after a stroke

High BP in young adulthood tied to brain changes in midlife

High BP in young adulthood tied to brain changes in midlife

Stroke risk elevated first 3 days post–COVID-19 diagnosis

Stroke risk elevated first 3 days post–COVID-19 diagnosis

Heart attack tied to decline in cognitive function later in life

Heart attack tied to decline in cognitive function later in life

Intra-arterial tPA boosts benefit of stroke thrombectomy

Intra-arterial tPA boosts benefit of stroke thrombectomy